Newtex Health to Present at JPMorgan's 43rd Annual Healthcare Conference by Investing.com

Houston, January 6, 2025 /PRNewswire/ — Nutex Health Company (“Nutex Health(or the “Company”) (NASDAQ: NUTX), an integrated physician-led healthcare delivery system consisting of 24 state-of-the-art micro-hospitals in 11 states and risk-taking, primary care-centric physician networks, announced today that it will participate in the largest healthcare investment symposium Sanitary industry “Symposium 43^Third annual JP Morgan Healthcare Conference. This event will be held from January 13^y To 16^y in San Francisco, California.

Nutex Health offer details:

Date: Thursday, January 16, 2025
time: 10:30 am ” 11:10 AM PT
place: Elizabeth B. Conference Hall in The Westin St. Francis Hotel in San Francisco

In addition to the formal presentation, company management will be available to participate in one-on-one meetings with eligible members of the investor community registered to attend the conference.

on Nutex Health Company

It is headquartered in Houston, Texas, and was founded in 2011. Nutex Health Company (NASDAQ: NUTX) is a healthcare management and operations company consisting of two divisions: the Hospitals Division and the Hospitals Division Department of Population Health Management.

The Hospitals Division owns, develops and manages innovative healthcare centers including micro-hospitals, specialty hospitals and Hospital Outpatient Departments (HOPDs). This division owns and operates 24 facilities in 11 states.

The Department of Population Health Management owns and operates networks of providers such as independent (LON:) Physicians' Associations (IPAs).

Forward-looking statements

Certain statements and information contained in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases “will” or “are likely to result in” are expected to, or “will continue,” “expected,” “estimate,” “expected,” “intend,” “goal,” or similar expressions intended to identify “forward-looking statements” within the meaning of the respective securities. Litigation Reform Act of 1995. Such statements are subject to certain known and unknown risks and uncertainties, many of which are beyond the Company's control. These uncertainties and risks include, but are not limited to, our ability to successfully implement our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprise Act, economic conditions, dependence on management, and the mitigation of Risk severity. shareholders, lack of capital, the effects of rapid growth on the Company and management's ability to respond effectively to growth in and demand for the Company's products and services, newly developing technologies, the Company's ability to compete, and conflicts of interest in related matters. Partisan dealings, regulatory issues, technology protection, lack of industry standards, effects of competition, and the company's ability to obtain future financing. An extensive list of factors that could affect future results is discussed in the Annual Report on Form 10-K for the year ending. December 31, 2023 And in the quarterly reports on Form 10-Q for the ending periods March 31, 2024, June 30, 2024 and September 312024 under the title “Risk Factors” in Part One, Clause (A) thereof, and other documents that are submitted from time to time with Securities and Exchange Commission. These factors could adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed in this press release.